ATRC: AtriCure, Inc. Stock

by  •  • Comments Off on ATRC: AtriCure, Inc. Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 1,133.90
Enterprise Value ($M) 1,059.74
Book Value ($M) 466.17
Book Value / Share 9.64
Price / Book 2.43
NCAV ($M) 118.48
NCAV / Share 2.45
Price / NCAV 9.57

Profitability (mra)
Return on Invested Capital (ROIC) -0.06
Return on Assets (ROA) -0.05
Return on Equity (ROE) -0.07

Liquidity (mrq)
Quick Ratio 2.66
Current Ratio 3.57

Balance Sheet (mrq) ($M)
Current Assets 266.25
Assets 613.93
Liabilities 147.76
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 399.25
Operating Income -26.68
Net Income -30.44
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 4.48
Cash from Investing 21.82
Cash from Financing -0.03

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Alliancebernstein L.p. 7.20 -4.82
02-13 13G/A Vanguard Group Inc 10.06 0.42
02-01 13G/A Invesco Ltd. 2.50 -65.49
01-25 13G/A BlackRock Inc. 8.80 12.26

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-16 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ¨ TRANSITION REPORT PURSUANT T
2023-07-26 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ¨ TRANSITION REPORT PURSUANT TO SEC
2023-05-03 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ¨ TRANSITION REPORT PURSUANT TO SE

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-17 120,578 557,130 21.64
2024-04-16 170,456 363,204 46.93
2024-04-15 174,351 482,085 36.17

(click for more detail)

Similar Companies
CERS – Cerus Corporation CLGN – CollPlant Biotechnologies Ltd.


Financial data and stock pages provided by
Fintel.io